Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +42.87%
#2 Unipoly Unipoly +41.52%
#3 Useless Coin Useless Coin +30.00%
#4 0G 0G +29.98%
#5 SAFEcoin SAFEcoin +29.29%
#6 Zora Zora +22.15%
#7 Seeker Seeker +21.36%
#8 Dogs Dogs +21.33%
#9 Pons Pons +20.75%
#10 Fake World Assets Fake World Assets +17.63%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Impact Therap-b Impact Therap-b

Impact Therap-b

7630
Rankning i aktier #13198
IMPACT Therapeutics, a biotechnology firm, specializes in the discovery and... IMPACT Therapeutics, a biotechnology firm, specializes in the discovery and advancement of precision anti-cancer treatments rooted in synthetic lethality, operating across China and international markets. The company's primary offering, Senaparib (IMP4297), is a PARP1/2 inhibitor currently deployed as a first-line maintenance therapy for ovarian cancer. Beyond this, Impact Therapeutics maintains a robust pipeline of investigational drugs. This includes IMP1734, a next-generation PARP1 selective inhibitor undergoing Phase I/II trials as a standalone treatment for advanced solid tumors. Another promising candidate is IMP9064, an ATR kinase selective inhibitor, also in Phase I/II clinical studies for advanced solid tumors as a monotherapy. IMP1707, a PARP1 selective inhibitor capable of penetrating the central nervous system, is in Phase I development for homologous recombination repair-deficient tumors. Additionally, IMP7068, an advanced WEE1 inhibitor, is progressing through Phase I/II clinical trials for various advanced solid tumors. Furthermore, a range of other compounds, namely IMP22, IMP25, IMP08, IMP13, IMP10, IMP27, and IMP32, are in the preclinical development phase. The company, established in 2009, is headquartered in Shanghai, China.
Aktiekurs
$1.85
Marknadsvärde
$510.85M
Förändring (1 dag)
-7.37%
Förändring (1 år)
-
Land
CN
Handel Impact Therap-b (7630)

Kategori

Healthcare
Utdelningsavkastning för Impact Therap-b (7630)
Utdelningsavkastningen (TTM) för Impact Therap-b (aktiesymbol: 7630) per 2026 är: 0
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.00%
Historik för utdelningsavkastning för Impact Therap-b (7630) från 2026 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter
Företag Utdelningsavkastning Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
0.57%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
2.01%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
2.74%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
2.69%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
2.47%
US